Patent Assignment
Reel/Frame 030401/0461
Security Agreement
Recorded: 2013-05-13
Received: 2013-05-13
Pages: 40
Assignors
CEQUENT PHARMACEUTICALS, INC.
Executed: 2012-05-03
MARINA BIOTECH, INC.
Executed: 2012-05-03
MDRNA RESEARCH, INC.
Executed: 2012-05-03
Assignee
MONSANTO COMPANY
800 N. LINDBERGH, BLDG. E2NR, ST. LOUIS, MO, 63167, UNITED STATES
Covered Properties
(41)
Hybrid Plate System and Method
Application:
13/722,264 →
Amphoteric Liposomes Comprising Imino Lipids
Application:
13/378,484 →
Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome
Application:
13/350,137 →
Components for Producing Amphoteric Liposomes
Application:
13/291,650 →
Synthesis and Uses of Nucleic Acid Compounds with Conformationally Restricted Monomers
Application:
61/532,056 →
Una Oligomer Structures for Therapeutic Agents
Application:
13/130,032 →
Compositions for Bacterial Mediated Gene Silencing and Methods of Using Same
Application:
13/196,436 →
Amino Acid Lipids and Uses Thereof
Application:
13/076,158 →
Amphoteric liposomes
Application:
12/807,707 →
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Application:
12/870,989 →
Amphoteric liposomes
Application:
12/806,342 →
Amphoteric Liposomes Comprising Neutral Lipids
Application:
12/682,703 →
Lipopeptides for Delivery of Nucleic Acids
Application:
12/750,622 →
Phage Displayed Cell Binding Peptides
Application:
12/701,397 →
Bacteria Mediated Gene Silencing
Application:
12/632,985 →
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
Application:
12/580,250 →
Construction and Use of Transfection Enhancer Elements
Application:
12/448,452 →
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Application:
12/515,403 →
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Application:
12/445,868 →
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Application:
12/445,575 →
Amphoteric Liposome Formulation
Application:
12/085,893 →
Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances
Application:
12/225,030 →
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Application:
12/206,165 →
Serum-Stable Amphoteric Liposomes
Application:
10/594,553 →
Amino Acid Lipids and Uses Thereof
Application:
12/114,284 →
Lipids and Lipid Assemblies Comprising Transfection Enhancer Elements
Application:
12/004,154 →
Phage Displayed Trp Cage Ligands
Application:
11/955,207 →
Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same
Application:
11/793,429 →
Transflective Liquid Crystal Display
Application:
11/834,376 →
Amphoteric Liposomes and Their Use
Application:
11/745,003 →
Phage Displayed Cell Binding Peptides
Application:
11/627,863 →
Amphoteric Liposomes
Application:
11/590,357 →
Ph-Sensitive Cationic Lipids, and Liposomes and Nanocapsules Containing the Same
Application:
10/505,107 →
Components for producing amphoteric liposomes
Application:
10/505,093 →
Phage Displayed Trp Cage Ligands
Application:
10/976,942 →
Amphoteric Sterols and the Use Thereof
Application:
10/468,654 →
Sterol Derivatives, Liposomes Comprising Sterol Derivatives and Method for Loading Liposomes with Active Substances
Application:
10/468,652 →
Pyrido[2,3-D]Pyrimidine and Pyrimido[4,5-D]Pyrimidine Nucleosides
Application:
10/221,397 →
Novel Nucleosides Having Bicyclic Sugar Moiety
Application:
10/136,932 →
Amphoteric Liposomes and Their Use
Application:
10/081,617 →
Pyrrolo[2,3-D]Pyrimidine Nucleoside Analogs
Application:
09/797,549 →